While low PCSK9 and LDL-C levels may not reduce baseline stroke risk, PCSK9 inhibitors (PCSK9i) help reduce stroke incidence in patients with high cholesterol and high risk of cardiovascular disease. Here, PCSK9 is linked to Stroke.